patients University multiple disease United sclerosis treatment study Background: Conclusions: Methods: Objectives: Results: clinical using MRI EDSS States, Neurology, Department cognitive associated lesions disability age compared MS. mean data risk years levels analysis Multiple significant Hospital, group significantly time used baseline lesion Medical higher University, brain Hospital .). effect RRMS Sclerosis patients. CSF studies score healthy showed patient activity relapsing-remitting States increased relapse controls progression (MS) treated Center, matter p< fingolimod included results Italy, new effects Patients volume year EAE (p< observed number progressive vs. Canada, including model efficacy onset total (.%) cells early subjects Medicine, lower patients, performed reported Clinical Research (%) different impairment MS, differences performance < based duration months diagnosis therapy cell changes follow-up safety cortical .), reduced groups active prior vitamin association control correlated School imaging MA, assessed scores test expression placebo did measures white DMF Institute assess identified increase rate use mice relapses atrophy However, measured cord prevalence received related findings functional high natalizumab Neurology interferon Center NY, New cases cohort phase spinal CIS Germany, investigate San Spain, change correlation inflammatory median regression difference delayed-release role clinically impact weeks Health criteria long-term memory SPMS Scale Disability Mean evaluate presence relapsing level p=.). (MS). Test course years, decreased analyzed (.) Institute, defined population primary serum versus demyelinating immune Basel, potential incidence ON, demonstrated index information neurological outcomes present ratio similar status study. days determine followed specific IgG according analyses individuals period autoimmune common obtained loss processing relationship respectively. .±. IFN confirmed diagnosed factors important alemtuzumab dose severity (p=.). following tests Status biomarkers events fatigue secondary Department, function isolated reduction costs health identify rates response study, blood disease. evidence damage matched NMO Switzerland, average genetic Netherlands, receiving years. (n=) evaluated gene greater resonance sample speed Cognitive Expanded age, group. randomized treatment. positive teriflunomide France, Neurological Sciences, adverse compare -year ARR Cambridge, assessment better development magnetic participants proportion relative symptoms trials CNS SDMT central estimated p=.) single suggest therapeutic QC, York, conducted controls. diagnostic optic revealed improved low motor overall detected developed experimental human protein (.% axonal beta-a chronic connectivity remitting (mean (p=.) Amsterdam, IL- Toronto, day executive individual likely month times Kingdom, considered longitudinal measure normal samples support trial underwent Medicine administered available fluid global groups. second severe DMT McDonald NTZ aim children collected consistent cost examine free glatiramer previous profile > (RRMS) Treatment acetate characteristics genes oral possible provide worsening (%), Data examined frequency lesions, syndrome IFNB-a Italy annual cerebrospinal diseases extension highly independent life neuropsychological outcome pathology physical previously report therapies Centre, FREEDOMS Raffaele State approved completed daily impaired large markers months. nervous quality screening sustained tissue (EDSS) Buffalo, Centre Neuroscience, Research, Year areas burden increasing lymphocyte β-a -month Boston, Brain CA, Norway, Pharmaceutical Unit, influence novel point pts Australia, Clinic, National battery calculated care encephalomyelitis group, highest known population. research seen standard structural studies. task women (.%), ,,, Biomedical Health, PEG-IFN TX, cerebral disability. exposure induced inflammation parameters people prospective regions scale selected statistically (n=), CI: Phase distribution dysfunction network shown sodium tool Barcelona, Inc., Milan, ability activation approach area demographic determined disorders laquinimod linear longer range sclerosis: sensitive superior tolerability type (., (MRI) .-.) Dept. adjusted affected annualized antibody current definite differ follow gender, mass negative statistical (OH)D Germany OH, abnormalities acute analysis. case correlations decrease modifying plasma remained smoking subcutaneous subgroups suggesting values (MS), Houston, IgM Montreal, NJ, Teva demyelination dimethyl enrolled improvement indicate left myelin p=.), presented (OR .%, AEs Canada Division London, Natalizumab Radiology, Sweden, consecutive conversion effective general intrathecal logistic majority metabolic odds predicted recovery sensitivity tested variables visual Düsseldorf, Novartis attention characterized count cross-sectional depression evolution experienced grey history initial interaction models oligoclonal progression. social stable temporal understanding variants work Digit Industries, Neurosciences, PA, Symbol accumulation and/or cognition comparison drug duration, factor female fumarate gray mainly medical predict ratios volumes BICAMS Biogen CARE-MS Fingolimod General Modalities Ottawa, associations concentration forms gender intake investigated need pediatric peripheral receptor sex thickness (range MRI. Neuroimmunology Psychology, Republic Stockholm, activity. clinic combined corpus direct disease, end explore expressed initiation involved loci main order region regional relevant respectively, retrospective scans subgroup susceptibility thalamic younger CDP Cleveland, Karolinska LAQ Spain Using Vitamin antigen baseline, comparing confidence dosing environmental established functions images lesions. line measurements patterns practice strong visit (SD) Analysis BPF Brief Experimental antibodies confirm cortex estimate experience features frequent objective pediatric-onset recruited required studied suggests symptom treatment, treatments (%). Danish Disease Fatigue MD, McGill Nottingham, PPMS QoL SNPs St. Study acquired addition, additional adherence aimed component controls, derived despite disease-modifying expected groups, having include larger major patients’ period. post predictors recent small thalamus trend years) (p=.), Argentina, Buenos MOG Philadelphia, Scientific Universitario Vall applied approximately beta conventional core counts demonstrate doses especially lack learning mechanisms placebo, posterior predictive quantitative recall receive relation responses specificity testing underlying value verbal (CSF) Assessment BID Cleveland Denmark, Israel, Kappos NFL PASAT Science Texas administration biomarker callosum complete complex data. date degree given moderate monoclonal neuronal optica p=. presenting proteins questionnaire ranged stages start studies, trials. weeks. worse Aires, Bergen, Copenhagen, Furthermore, International January MRI, NMOSD Results Rome, astrocytes bands commonly corresponding data, effectiveness fraction frontal functioning hospital integrity long occurs particular pathological placebo-controlled sex, visits vivo working (.%). (.), .-.; Birmingham, CHU DTI HYP Japan, NAWM PBO RRMS. Sweden Switzerland T-weighted Turkey, Universitari York accuracy continuous deficits differential evaluation extended follow-up. management mg, mice. neuromyelitis newly occur pattern pooled preliminary recently recorded registry reliability result significance size terms weighted (.±. Alemtuzumab BMS CONFIRM Compared European HLA Imaging Institutet, LS-OCMB Oslo, Ottawa Participants The analysed classified detection discontinuation estimates frequently however, increases levels. mechanism method mild monitoring needed protocol provides reduce soluble started suggested therapy. unique validated various years; −., .-.). Auditory Berlin, Bordeaux, Brazil, Group, Idec Moreover, Pharma School, Vita-Salute addition anxiety cognitively comparable correlate correlates criteria, currently divided earlier episodic extensive females final finding future help impairment. included. includes key model, monthly mouse neurologists observational occurred onset. open-label reductions relapsed respectively). right scan strongly survey suspected therapy, time. urine variability (all .%; Barkhof Comi Company, Faculty Heinrich-Heine IL, Kingdom Molecular Mount Netherlands NfL Public Sanofi Stony VPA able absence activated components controlling diffuse diffusion economic elevated fMRI family gadolinium-enhancing gradient hypointense inclusion influenced integrated involvement medication miRNA model. multivariate n=) needle of, older percent percentage performance. production radiological represent review signs starting state taking term unknown. useful weekly weight {border-style (.-.) (RRMS). (WM) -week .-.), BMI California Functional Genzyme, III Italian Life P< PBVC Pediatric Prague, Service TIW adults aged altered analysis, atrophy. beneficial cells, cervical cohorts cytokine delayed detect disorder does enhanced event gait hippocampal interval marker men nerve neuritis numbers old parenchymal pathogenesis pathway play points protective reference remaining remains resulted sequences survival target young (median AB, AG, Bochum, DAC EAE. Finally, High Magnetic Montalban Zurich, allows benefit binding body characterize composite connected contrast cytokines drugs duration. examination good healthcare improve later lymphocytes male maximum mediated mortality observation onset, outpatient peptides period, placebo. population-based px;} reaction regarding regulatory relapse. remain segmentation set software status, tracts twice understand untreated upper version widely year. #ffffff;} (HR (NCT) (RR) (r=−., -OH -hydroxyvitamin .%) ARNT BBB CD, City, EDSS. Francisco, Harvard Hôpital MS-related MSFC Oxford, Patient RRMS, Serial Statistical Women’s affect alterations basal baseline. benign combination continued deficiency described develop diagnosis. evident explained extracted focal genotype hoc hypothesis immunomodulatory incident indicated indirect lead leading light measuring months, ongoing past pathways peak poor potentially presented. processes randomized, reduces reducing relatively reliable reserve satisfaction score, spectrum subsequent substance systemic tract trial. volume, (CIS) (DMF) (in (r=., Bari, British CO, Clinic Czech DEFINE Dallas, Depression Efficacy Gd-enhancing HC.   -). -Isoprostane AQP Addition Age CBHs CCL CTIP College Columbia, Cortical DIR Despite EAE, EBV Foundation, Fox France Girona, HCs Hebron Hunter IPS Immunology, Linear Mental Montréal, OR=., PML Republic, Rochester, SF- Sassari, Time Translational Valencia, Verbal [., activity, air algorithm allele allow analyze animal arm axon behalf best cells. cerebellar chain cingulate claims controlled degeneration design determining diffusivity directly discontinued distinct entered evaluating excluded expanded factors. familial faster fully generated identification immunoglobulin interim late levels, likelihood liver metrics miRNAs monitor national negatively observed. paired patient’s performance, physician populations prescription probability properties published reach regardless retinal returned safety, sequence services sites spontaneous stage stress structures subcortical surface targeted titration utilization week weeks, were: years), (%, (HC) (N=) (±.) -.% -., -year, .mg .±., ADVANCE AL, ALLEGRO Arnold BVL Brook, CIS, Cagliari, Calgary, California, Comprehensive Cox DMTs East FSS Global Gold Group Hanover, Human Impact Izmir, Japanese Kim Lyon, MS: NC, NMO, Neuroimaging OCB P=.). Poland, RNA Rigshospitalet, SMT SNP Safety Santa Serpine Serum Sick Southern Swedish TOPIC Tesla Wayne Week abuse alternative analyzed. anterior appears automated bilateral blinded brains centers characteristic comorbidities comprehensive consistently criteria. critical demonstrates depressive diagnosis, differentiation disability, diseases. exhibited female) fit flow ganglia immunological importance increasingly individuals. infection inflammation, injury interactions intervention intramuscular layer led like living lobe males matching mg/day mg/mL monophasic n=), n=; needs neurodegenerative nuclear obesity peptide periods persistence power predictor problems random reached relatives reports require routine safe setting. sporadic structure switching tasks unknown used. validate virus (), (/) (ARR) (CNS) (EDSS (NMO) (age (n= (n=, According Alabama Baltimore, Based Belgium, Bethesda, Canadian Centro Chieti, December Delayed-release ELISA Epidemiology FTY HCs. HPP Imaging, Increased Japan London MIF NEDA Neurosciences Neurosurgery, North OR, Office, Padova, Questionnaire RR-MS Resonance Royal SPMS, Subjects Teriflunomide Unit Vancouver, Zhang acquisition adjusting adolescent age- agreement alpha analyses. anisotropy band beta-b candidate cause center classification condition conditions conditions. continuing contribution courses covariates curve daclizumab damage. database. dependent domain effects, epidemiological failed female, field findings. form frequencies hand hours immunosuppressive impairment, indicates infections inferior inhibitory initiated investigated. level, level. literature located mADS maintenance methods mononuclear n=). outcomes, panel parameters. persistent physicians pivotal possibly process quantified randomly rare regard relapses, relationships respectively scanned scored selection serve spatial spectroscopy step substantial subtypes switch system. test. therapies. treatment-naive types validity variance vascular women. %). (.-.), (A: (AEs) (DMT) (Gd) (NCT), (QW (RRMS), (natalizumab, (z=., -), .-., Additionally, April CNS.  (HC). (SDMT) (e.g. (i.e. .%. =., ACTIVE BL, Beck Biostatistics, Blood Buffalo CNVs Chicago, Consortium Denmark Dept Differences Europe FGL Fe, Freedman Further, GA, GALT Glatiramer IBD IL-, Idec, John Josef Laboratory Los MDT MS; MSSS MWF Massachusetts Montreal Münster, NAA/Cr NAT Naples, Norway Olsson Performance Pharmaceuticals Queen Science, Siena, South Studies T-cells TNF-α Therefore, Thus, Tohoku Weinstock-Guttman Ziekenhuis, access account acid adult age-matched age. asked assay assessment. balance barrier biological brief capture cardiac carried case-control causes changing childhood claim class cohort. concomitant containing converted costs. cytometry declined decreasing depth deviation discovery dose. driving easy efficacy, efficiency enable endpoints enrollment episode escalation everyday failure fatigue, fewer fingolimod. follows: function. glycoprotein goal groups: gut head humanized hypothesize i.e. immunomodulator implications initiating inpatient intravenously knowledge latitude link lumbar maps measures. met metabolites minimal monitored multiplex noted occurring oligodendrocyte partial participant participate patients: perspective phenotypes platform produced productivity profiling pronounced quantify rank rats recommended records region, region. regulation requires resolution response, resulting results, results. retrospectively second-line shows simple slower smaller specialized spectrometry status. strategy substantially sun symptomatic syndromes taken test, tests. threshold tolerated transcriptional transverse users valuable volume. %), %CI (> (EAE), (EDSS), (OR=.; (SPMS), (including .%), Anatomy Angeles, Argentina Australia BIIB Bach Banwell Baseline Baylor CI, CLs CSF-GFAP Catalonia, CogState Comparison Current D-ER DMF, DMN DST Dicer Direct Dokuz Dresden, Environmental Eylul FGM Federico Filippi Future GERS GNbAC Genetics, Geurts Havrdova Herbert Hillert Hispanic ISC Icahn Interestingly, JJG Johns Kansas Lausanne, Lesion MIS MN, MTR Margolin Milano, Months NYU Norwegian Novara, OASIS Phillips Physical Primary Program, RTX Relapsing Ruhr SA/DP SDP SPMS. Sciences Similarly, Sinai, Spatial Strasbourg, T-cell TRANSFORMS Tfh Thessaloniki, VCAM- Vollmer action activities adequate advanced affecting antigen-specific appeared areas. arms attributed auditory availability basic binomial bismuth capacity caused choice coefficient cohort, comorbidity comparisons computerized concentrations confirms contrast, corrected crucial delay demographics detectable diet difficult eEDSS echo enlarging equal evaluated. events. evolving examining existing explain express expressing expression. external financial flushing generations genotyped gyrus identifying improvements induce intensity intralesional inverse irrespective largely lateral leads lesion. mapping meeting mg), microglial middle molecule movements murine myelitis nationwide neural neuroprotective obtain occurrence option outside p=.; parameters, parietal participation pathogenesis. perception pharmacodynamic plus poorer primarily propensity prospectively pyramidal rat reactive receptors recorded. regions. relevance repeated replication resting reveals risk. scoring sex-matched site software. staining subjects. subpial suitable tools treatments. vasculitis walking water way wish withdrawal yielded ≥., >. (.%); (.); (BL) (DTI) (RR=., (SC (SC) (at -%, -.) -.; //-//, Additional Adjusted American B-cell Battery Bridgewater, Brook CIS. Changes Colorado, Considering Copenhagen Correlation Correlations Cutter DEFINE/CONFIRM DFC DMF. Diagnosis Disorders Dr. EMD EPO FILMS FMS Fetuin-A GmbH, Gorfine Graduate Gray HC, HIV HLA-DRB*: Haukeland Healthy Hospitals HspB Hutchinson IRT Identification Immunology Inclusion Indirect Individuals Isfahan, Isolated Israel Kister Kurukulasuriya Laguna, Lake Lille, Lodz, MS) Macerata, Multivariate Munich, NMO/NMOSDs NRG NeuroRx Neuromyelitis Odds PANGAEA PMS PRISMS Politècnic Population Preliminary Previous Prior Regarding Relative SPECTRIMS SUNY Salt Smoking Social Spinal SuS Subjective Technology, Thai Thalamic Till UT, Uitdehaag VCA VEPs Visuospatial WBC Walker Würzburg, [.] abnormal accurate acids added adolescence aims appearance appearing appropriate astrocytic attending autoimmunity. beginning calculated. characteristics, childhood-onset clinician cod completing computed consists contributed coronary correct correction cortex, corticospinal crude cultures cuprizone dGM days. deficient define demonstrating demyelination. depending der determinant diameter drive d’Hebron, earnings effects. emergency emotional excluded. experiencing fact far, fatigue. feasibility females) females, focus found. functions, generation glial group: heavy high-dose histological history, holes hypothesized incipient incomplete inducible infections, infiltration influences injections injury. international involving lipid lost lowest maintained manual marked maximal mcg method. methylprednisolone mixed modeling modulate modulation molecules n=, nature naïve near nearest needles new/enlarging ng/ml norms oil one-year overt paraclinical particular, pathophysiology patients; performing phase, pollutants positively potent practice. pregnancy probably processes. produce proinflammatory promotes proportional propose proposed prospective, protection psychiatric pulse puncture px; race radiologic ranging re-randomized recovered referred reflect regression. reliably representative representing resource resources respectively), reveal revised risk, sample, scale. scores, seasonal separate shift short- signal siponimod slightly somatic studied. subsalicylate subtle task, task. technique techniques tended tertiary took up. usefulness usually variant visits. vitro volumetric von voxels wGRS web-based wide widespread {font-family (.%, (.-.). (BID) (EAE). (FA) (PPMS) (SPMS). (for (p=. (pts) (r= (the (±.). ,). -(OH)D .%). ANOVA ATX AUC Aarhus Acetate Alexandria, Analyses Atrophy B-H BID/BID Baló Baló’s Benedict Biology, CBL/ CI) CMPD CVID Caen, Central Cerebrospinal Charité Chilly-Mazarin, Cologne, Colorado Comparative Composite DMT. DMTs. Diagnostic ECG EDSS-Plus Effect Epstein-Barr Evaluate FLAIR GA. GMV GWAS Giovannoni Greece, Halifax, Heidelberg, Hopkins Hospitalario Huang Hungary, IFN/GA IFNγ IIDD IVMP IgG-index Inventory K-M Khan LCN Laboratory, Lugaresi MSBase Melbourne Model Movement Myhr NS, Napoli, Network Neuropediatrics, Norway.  (N= (NTZ) (OR) (PASAT) (PD) (Q, (SP) (SPMS) (as (group (hazard (standard ,-,; ,±, -.), -/- .-. .-.] ./.; .]) ADVANCE, ANCOVA AOU ARCS Aarhus, Advanced Affiliated Age, Aim Alberta Argentina. Autoimmune BOLD-hemodynamic BRB-N Branch, Brazil CAID CBH CCA CCL, CDMS. CONFIRM, CSA CSF, CSF. CXCR, Calabrese Casanova Child Chitnis Chronic Clinically Clínico Cohen Costa DAF DEFINE, DMD DNA Daclizumab Dalhousie Decreased Demographic Diseases EMQ ENDORSE, ENDORSE. EVIDENCE Edmonton, Elevated Evaluation Findings Foley Foundation Function GDs GML Gallarate, Gan, GdE Genetic Genetics Genomics, German Girona Given GlaxoSmithKline, Glostrup Groups Guangzhou, Göttingen, HBD-S-H HLA-DRB Higher ICD- IFN, IFN-γ IFNB-a) IFNGA, IL-Rα INSERM ISR ISRs Impairment Incidence Index Inhibitory Institut Internal Josep July June Krupp LHON Lechner-Scott Lee Lewis Liu Liège, Long-term Louis, Lugano, MO, MOG-specific MS-associated MSIS- Mary Medicare Mice Montpellier, Motor Myelin NMO-IgG NMO. NMOBase NMOIg NMR Neurofilament Neurologische Neuropsychological Nevertheless, Nurr OCH Ophthalmology, P=.) PBS-treated PCs PVC Palmer Park, Partners Pearson Pennsylvania, People Pharmaceuticals, Physics Pooled Portugal Portugal, Pozzilli Program Pts RIS RNFL ROS Ramat Ramón Rehabilitation, Relapse Rennes, Rovira Russian SDMT, SHB SWI Salerno, Sato Self-reported Sellebjerg Serono, Sheba Sidi Similar Sydney, TBSS TEMSO TOWER Tehran Tehran, Test, Tewarie Therapeutics, Tlemcen Trojano Universitätsmedizin VAS Valladolid, Van WM, WML Winnipeg, Yat-sen Years Zivadinov accounted accounting accurately achieved adhesion adjacent adjust administrative adult-onset adults. age-standardized age: albumin analyse and, application assessed. autoreactive battery, biomarkers, biopsy bladder c-SDMT categories center. centers. changes. characterization chosen clear close comparative compatible complications composition concerning concerns conflicting consumption cord. corresponded count, curves debilitating decades decision della dependence destructive dietary differentiated difficulty discontinuing discriminate disorders. disseminated dosage double; driven drug, dual-task eQTL efficient engaged enriched enter epilepsy equivalent exacerbation examined. exception expert female; fixed formation fulfilling fusion genome genomic genotypes genotyping geographic globus greatest grouped growing guess guessed half-life hand, hazards height home illness images. imaging, immediately improving incremental indices induces infectious infratentorial inhibitor inhibits injectable inner insertion insight instead insula intact interleukin- interventions investigating lacking. lesions) limit liquid lymphoid magnitude maintaining manner. markers. methods. miR-, miR-a models, models. modified mood morphology multicenter, muscle needle, network, neuroimaging newly-enlarging non-users nucleotide ongoing, ongoing. optimized original outcome. p=,). paradigm parallel paraparesis pathogenic patient-reported pattern. peginterferon phage polymorphism poorly population, practice, precentral prediction prefrontal presenteeism procedures product prognosis protein, proton proven pts. r=., rAbs radiation range: real-time reason reasons reflected regions, regression, regular relate remote removed replicated requiring research. residual response. restricted retention risks sCD sampled scanner. scientific screened seconds segmented seizures self-report separated seropositive served seven signals signed significance. sizes skill soil sought sources space squares stained stopped stringent stronger strongest subgroup, subsets subtype, susceptibility. symptoms, systems temporarily testing, them, therapies, these, thinning transgenic trends treosulfan trough unclear unrelated variables, variables. variations word world µg/l Łódź, ‘G. $US, %CI:.-.) %→%, (%CI (). (-), (-. (-year (CDP) (CIS). (DMT). (DMTs) (Expanded (FC) (FSS) (GA (HR=.; (MSFC). (NAWM) (OCB) (ORs) (PBMC) (PBO) (QD) (QoL) (RRMS; (Years (defined (disability (p= (p=., (rate (severe, (t() -phosphate -years .-fold ./. .]). .]; .±.. /L; AAO ADS AFFIRM ALCAM Achiron Active Akbar Alberta, Algeria America Antonio, Aristotle Average BETAPAEDIC BID/BID, Bangkok, Bar-Or Belgium Berkeley, Biomedicine, CBL/J CI. CP-MS CSPG Calabresi Cancer Card Care, Carlos, Cases Caucasian Caucasians Ch/Cr Chang Charlson Children Christchurch, Classification Cocco Cohort College, Columbia Comabella Conventional Costs DIT Daams Daily Dangond Database Departments Dept., Dex Diffusion Don Dukovic ELISA. ERs Early Eastern Enzinger Executive Extended FSL FTT FTY. Fazekas FreeSurfer Frohman Fukuoka, GSH Genes Gnocchi Grey H-P HCU Hartung Here, Hispanics Hordaland Hulst IFNB-a. II, IMSE IRCCS IgG, Independent Individual Inflammatory Instituto Izquierdo J-P Jager Janeiro, KS, Kaplan-Meier Kyushu L-carnitine LAS LFC LHON-MS Larger Latin Lesions Leuven, Lower MACFIMS MDSCs MHC MIF-/- MPIOs Macarena, Main Making Manitoba, March Marrie Martin McDonald’s Measurement Minimal Moldova, Montréal Morra Møre NAB NBV NIH, NMOSD. NcoI NeuroPsychiatric Neuroradiology, November Nuclear ORs Optic O’Connor P-MSSS PBMC PBO/BID, PCP PDDS PEA PK/PD PLC PPMS, PSIR Percentages Pharmacology Pharmacology, Pharmacy Pittsburgh, Portland, Poser Potential Poznan, Progression Progressive Prosperini RNAs RS-FC Reduced Rees Rehabilitation Reich Rio Rock, Rockland, Round SPM.  (NMOSD) (ON) (P=.). (PASAT). (PBVC) (QW) (SD), (SR=.; (baseline (disease (e.g., (males-.%, (month (n=,) (no (on (one (r=.; (sex, (z=−., (±) (±SD) (β= -HPT -Hole -point -step -year-old .%→.%, .], .→., =.; AA/Cr AEs. ALT ATAVT Adherence Adverse Affymetrix African-Americans Agilent Akershus Akron, Alcalá Alfredsson Algeria, Although, Annual Antwerp, Anxiety Application Approximately Association Athens, Axonal B-cells BMCs BPF, BPV BRB Bacon Balk Barnabas Barts Basic Bayer Bayesian Berard Bergsland Berrigan Biochemistry, Biology Biomarkers Biostatistics Blizard Boneschi Bonferroni Boscá Boz Brochet Butzkueven C-C CCS CD) CD. CHIL CI] CRIDD CSF-GFAP/MBP CXCL CXCL, Cajal Canarias, Cardiff, Chamot Charlotte, Chen Chin China City Coimbra, Collins Columbus, Competence Complejo Complex Controlled Coret County County, Currently Currently, DC, DECIDE DGMLs DLPFC DMT, DOD DR-α Dahlke Demyelinating Dentistry, Determine Discovery Diseases, Disorders, Duquette EBNA- EDSS) EED EOMS ESC Economic Education Eligible Encephalomyelitis Erasmus Evaluation, Evidence Evidera, FLAIR, Faculty, Faculté Fang February Federation, Fenu Ferreira First Florence, Fractional Frederiksen Free French Fuchs GA/BID, GCS GFAP Gallo Gascón Gastrointestinal Gd-enhanced Gene Georgetown Germans Ghezzi Gierer Gilenya González Greece Greenberg Groningen, Gustav HADS HLA-A*: HPT Hart Healthcare, Hellenic Hobart, Hojnacki Holy Horakova Häring IEF IFN-beta IFN-g IFNB IFNGA IFNGA): IFNGA. IIDCDs ILRA, IMT IPe ISVF Impaired Importantly, Increasing Informatics, Innate Innsbruck, Intrathecal Iranian J-C Jordan Karadeniz Kieseier Killestein Kinter Kolodny Kurtzke Kuwait, LAQ, LETM LS-OCMB- Ladkani Langone Leiden, Leone Levels Lexington, Logistic Lorefice Lourie Ltd, Luigi Lysenko L’Aquila, MB, MHCII MPRAGE MRI: MRS MS-RR MS-like MSFC. MSP MSPs Maggiore Magyari Major Mann-Whitney MarketScan Marrosu Martinos Max McGuigan Measures Meier Metabolomics Mexican Mitochondrial Monaco Montpellier Moore München, NAWM. NHS NMO/NMOSD NMOsd NTZ, Nakashima Navarré Negative Neurologia, Next, NfH Nijmegen, Nineteen Normal Notre OA-treated ON. OPN October Odense Ohio Orbassano, Oreja-Guevara Orkney OspC Overall O’Connell P., PBO/TID, PBVC, PDPH PEA-um PEARL PGRN PGV PJW POPARTMUS Paris, Paul Peg Pereira Persistence Petach Point Post Post-hoc Pouwels Propensity Pugliatti Pujol, Pérez-Miralles Q), QALY Quintana RLS RRs RSN Radue Ramió-Torrentà Rao Ratio Rebif Regionale Register Registry, Relapsing-Remitting Related Rey Rocca Rochester Rotterdam, Rouen, Rudick Ruhr-University SD=.) SPMS) SPMS: SPSS Salzburg, Samples Santiago Sastry Satisfaction Schoonheim Schwartz Sclerosis, Sclerosis. Secondary Significantly Society Sorosina Southwestern Spearman Specific Sperling Stanford Statistics, Structural Subsequently, Sørensen T*-weighted TDL TDLs TEAEs TID.


{{ $bootstrap := resources.Get "sass/bootstrap.css" | resources.Minify | resources.Fingerprint }} {{ $style := resources.Get "sass/main.scss" | resources.ToCSS | resources.Minify | resources.Fingerprint }} {{ $favicon := resources.Get "images/favicon.ico" }} {{ $image := ((index (shuffle .Pages) 0).Params.image) }} {{ $picture := (resources.Get (printf "%s" $image)).Resize "1200x q75" }} {{ partial "og" (dict "title" "{{.Params.Title}} - Projects list" "image" $picture.Permalink "type" "website" "description" "Projects I created or participated" ) }} {{ partial "fonts" }} {{ partial "ga" }}
Technologies: {{ partial "project-technologies" (dict "Technologies" .Params.technologies) }}
{{.Params.shortDescription}}
Have a deeper look


Clipboard
=========
Many of the steps in this tutorial will be easier to copy and paste
into the Dev Environment.
To copy and paste in the Dev Environment App,
you will need to use the keyboard.
On your platform use:
* |copy_key| to Copy
* |paste_key| to Paste
.. |copy_key| raw:: html
Loading...
.. |paste_key| raw:: html
Loading...


Ploror688.github.io
If you need help with statistic homework we are a perfect place for it. We guarantee the high quality of each completed task.
Lightwire provides fast, reliable rural broadband. Our wireless high-speed internet is available in Waikato and Bay of Plenty. Check your coverage using.
Universal Essay: Do your homework nz essay writing service. Home Builder Reviews and Suggestions. Do you want us to send you a course information pack in the post? We can only post course information packs to New Zealand addresses. Your child's primary school years go from year 1 to year 8. In this section you'll find out what types of schools are available, how to choose one that suits.
Welcome to the Boys Forward Institute. English Language Partners NZ Learn English Today.
Latest information on new consumer protection measures CONTRACTORS: DO YOUR HOMEWORK. Home-buyers can do plenty building themselves to guard against their biggest. Do your homework A contractor’s guide to rights and obligations when contracting with homeowners. ITM are your local Building Supplies Specialists. For all of your trade requirements come and talk to your local ITM. LBP, Licensed building practitioner, LBP points.
Maths Centre - The NZ Centre of Mathematics.
Do Define Do at Dictionary.com. Do your homework nz to write about essay on greed for money and power. Do you homework do your nz take the next section, we defined intensity as a different NZQA New Zealand Qualifications Authority Mana Tohu Matauranga O Aotearoa. Site map Contact us Login. Search.
Do Your Homework Building Nz - dionysos-systemes.com.
Do Your Homework Building Nz – Do your homework. Holiday homework - class – vi b maths - do check your progress on pg 10,11,79,80,112,113 in maths ii n.b. under heading maths practice eng. lit. - learn revise. Home-buyers can do plenty by themselves to guard against their biggest investment becoming a nightmare. Stunning views were destined to be short-lived for residents.
6 Key Marketing Do's and Don'ts For Your Startup - Forbes.
Get Started with MathsCentre Welcome to the NZ Centre of Mathematics, the access point for quality mathematical videos, textbooks and maths games. Complaints about your early childhood education service. If you have an issue with something at your child's early childhood education (ECE) service or kōhanga. Do definition, to perform (an act, duty, role, etc.): Do nothing until you hear the bell.
Primary school Parents.education.govt.nz.
New Zealand Sign Language . how to support your child to do their homework, . out their approach to homework. If your child’s school doesn Doyourhomework.co.nz - Building Performance. HOME WORK – SUMMER VACATIONS HOLIDAY HOMEWORK - CLASS. Lightwire Rural broadband internet provider, Waikato. Kurt Hollis / Whether you want to take the next step in your career, or fill an important role on your team, Kurt appreciates the quality of relationship Do you need a food control plan for your premises, call us on 09-826-1920 We are your Food Safety and Liquor experts. Homework (Daft Punk album) - Wikipedia.
Links to websites for children and parents including things to do, homework help, search engines for kids, parental advice and safe surfing. ITM - Your Building Supplies Specialists. Don’t waste your time networking with strangers. Start networking smarter and smaller. Invite key people for coffee or lunch one-on-one
We have gathered a team of experts with prominent academic credentials in different disciplines. We are ready to do your homework 24 hours a day. Our prices. Conception et Fabrication 100% Française # Latest information on new consumer protection measures. Home-buyers can your plenty by your to guard against their biggest. REMEMBER. Do not rely on others for financial information – knowing about school finances is part of being a principal. If you don’t Statistics Homework Help Assignment Help with Statistics. Looking at property? Need advice on a development project or unit titles? AlexanderDorrington can enable you to achieve your goals.
Contact Us at The National School of - nasa.co.nz. Understanding school finances / Guides for managing.
Learn English language skills you need to participate in all aspects of life in NZ. We deliver high quality, low cost programmes in 23 centres nationwide.
How to Write a Winning Proposal Plan A - company. Useful Websites for Kids - The Big Project. Napier Libraries comprise of Napier Library and Taradale Library in Hawke's Bay, New Zealand. Napier Libraries offer extensive book and resource collections Homework is the debut studio album by the French electronic music duo Daft Punk, released on 20 January 1997 by Virgin Records and Soma Quality Recordings. A Ten Step Plan Let’s face it, developing business proposals or tenders is probably not your core business. But the difference between a great tender
To Do Homework is Not a Problem Anymore. As successful Dunedin accountants, we understand the challenges you face. Let us take the load off your shoulders and help you build a better, and more profitable.
Alcohol Food Consultant - Food Safety
Latest information on new consumer protection measures. Home-buyers can do plenty by themselves to guard against their biggest investment becoming a nightmare. PeerWise is used in a wide range of subjects, including Anthropology, Biology, Chemistry, Computer Science, Physics, Population Health, Pharmacology, Medicine Napier Libraries - Napier and Taradale Library. Visa for New Zealand Tourism New Zealand. Doyourhomework.co.nz - Building Performance. Do your homework: A contractor’s guide to rights. Complaints about your early childhood education service.
Homework Parents.education.govt.nz. Do Your Homework Building Nz - theater111.ch. Alexander Dorrington - Specialist property
From the Original Admin person: “I was looking for home building companies, and came across a number of builders. However what I didn’t find was a review. Answers.com is the place to go to get the answers you need and to ask the questions We enjoy welcoming visitors to New Zealand. To ensure you have an experience to remember, make sure you’ve done your homework and have everything sorted before. Maths Centre - The NZ Centre of Mathematics Year 9 Week 14 You will find that the first set of odd arithmetic exercises will need a calculator, however. Ian conducts informative Teacher, Parent and Corporate sessions and workshops throughout Australia. Find out about upcoming seminars in your state. Answers - The Most Trusted Place for Answering Life's.


Hello! I'm Sami, an artist and aspiring web developer from Washington State. I currently live just outside the Seattle area with my fiance, and our tabby cat named Kirby. With the current change in the world, it gave me the push to jump into a field that I've always been interested in but never felt like the 'right' time to pursue. With a background in the arts and graphic design I felt it would be a great tie in to my current lifestyle and passions.
Currently still working on getting more and more proficient with web coding and getting to learn different languages and styles, but have found that I am most interested in the graphic layout and formatting aspect! Excited to keep working through my bootcamp classes to learn more and get even more comfortable creating fun, visually attractive, and interactive pages.


Pat's Salmon Cookies
"A delightful treat from the Pacific Northwest!"
Serving all your Salmon cookie needs!
Frosted Salmon Cookies: One of our most popular items! Available in gift packages of 6 ($8), 12 ($15), 24 ($28), and 36 ($38)!
Salmon Cookie Cutter: Make your own salmon shaped cookies to celebrate one of Seattle's most beloved residents! Supplies limited! ($19)
Pat's Salmon Cookie T-shirt: Here at Pat, we wear our favorite fish on our sleeves! Wearing this T-shirt, you can feel the cool waves of Puget Sound washing over you. Supplies limited! ($25)


Welcome
Welcome to the new medical card application demo, you can begin by
Clicking here
Or selecting New Application from the menu in the top left.
New Application
Contact Information
Select GP
Declaration of consent
I declare that I am an ordinary resident in the state, and that the information that I have given, as part of this process is correct to the best of my knowledge.
I agree to tell the HSE of nay change(s) that may affect whether my eligibility for a Medical Card or GP Visit Card I will also tell the HSE if there is any change that may affect whether or not my spouse or partner (if any) is eligible for the Medical Card or GP Visit Card.
I agree that the HSE, when assessing eligibility, may contact the Government Departments including the Department of Social Protection, the Revenue Commissioners and the Department of Justice to confirm the information that I have given.
I apply for an assessment of eligibility for myself and my spouse or partner (if relevant). I am applying with the knowledge and consent of those named in the registration.
Data Protection and Freedom of Information Notice
The HSE will treat all personal information and data you provide as part of this application as confidential and store it securely. When the HSE receives your application and supporting documentation, it will make a computer record. This record will contain the relevant personal information you have supplied and will be used and retained by the HSE, solely for the purposes of assessing your eligibility (and that of your spouse, or partner if relevant and named dependants) under the Medical Card scheme. Anonymized data may be disclosed to the other bodies for the purposes of providing health service. Any disclosure will be in accordance with the laws relating to the proper treatment of data.
The HSE will not disclose (share) to the other people or organizations the personal information you have given unless permission has been given by the person to whom the information relates or the HSE is required to do so by law.
Users
This is the users section
AddyRob
Chuck
Sam
User: {{params.name}}
Contact
This is the contact section


We know what college students have been through during these difficult times and want to help them.
If you are a new user and want to contribute to our college student community, please sign up.
Sign in if you are already an user.


tinySIS seems to have had a problem. The volunteer staff member who administers this website has received an automated email with detailed information regarding this crash. Although it is possible that data was lost, it is unlikely. We will sort it out as soon as possible. If you would like to send additional feedback about this crash, please send email. Thanks for your patience.


July 1856
Nikola Tesla is born in Smiljan, Austrian Empire (now Croatia).
1875-1878
Enrolls at Austrian Polytechnic to study electrical engineering. Drops out without finishing his degree in December 1878.
1882
Moves to Paris and begins work as an electrical engineer with Continental Edison Company. Experiments with magnetic-field-based devices and comes up with idea for induction motor.
June 6 1884
Arrives in United States with little money and a letter from a former employer recommending him to Thomas Edison.
1885
Quits his job working for Edison due to unfair compensation for overhauling and improving the efficiency of Edison's motors.
1886
Founds Tesla Electric Light & Manufacturing Company in Rahway, New Jersey.
1887-1890
The War of Currents rages, ultimately culminating in a victory for the alternating-current model of electrical generation (over against Edison's direct-current model) developed by Tesla and championed by his associate George Westinghouse.
1887-1895
Experiments with X-Rays using his patented single terminal vacuum tubes. Nearly all his X-Ray experiments are destroyed in a fire at his lab in March 1895.
1891
Patents the Tesla coil.
July 30 1891
Gains United States citizenship status.
1893
With Westinghouse, powers the World's Columbian Exhibition in Chicago and displays the powers of alternating current for the world to see.
1899
Relocates his research to Colorado Springs, where he begins conducting experiments of higher voltage, higher frequency, and over longer distances.
1901-1905
Constructs Wardenclyffe Tower on Long Island, New York. Due to waning interest from investors and his own failing finances, Tesla ended up abandoning the project unfinished.
1913
Patents bladeless turbine engine.
1916
Files for bankruptcy.
1934
Theorizes on the possibility of inventing a "death ray" using a concentrated particle beam to project large amounts of energy over long distances.
January 7 1943
Tesla dies of heart failure. The cremated remains currently reside at the Nikola Tesla Museum in Belgrade, Yugoslavia.
For more information about Nikola Tesla's life and work, check out his Wikipedia article.


|
shared_memory
|
Implement a shared array stored on a shared memory segment. More...
#include <array.hpp>
Public Member Functions | |
| array (std::string segment_id, std::size_t size, bool clear_on_destruction=true, bool multiprocess_safe=true) | |
| ~array () | |
| wipe the related shared memory segment if clear_on_destruction is true (true by default) | |
| array (const array< T, SIZE > &other) | |
| this array and other array will point to the same memory segment, and will have same values for clear_on_destruction and multiprocess_safe | |
| array (array< T, SIZE > &&other) noexcept | |
| This array will point to the share memory segment pointed at by other; and will have same value for multprocess_safe and clear_on_destruction. More... | |
| array< T, SIZE > & | operator= (array< T, SIZE > &&other) noexcept |
| This array will point to the share memory segment pointed at by other; and will have same value for multprocess_safe and clear_on_destruction. More... | |
| void | set (uint index, const T &t) |
| set element t at index | |
| void | set (uint index, const T *t) |
| set element t at index | |
| void | get (uint index, T &t) |
| read element at index into t | |
| void | get (uint index, T *t) |
| read element at index into t | |
| std::size_t | size () const |
| max number of elements in the array | |
| void | print () |
| print in terminal info about array's memory usage | |
| void * | get_raw () |
Private Attributes | |
| boost::interprocess::managed_shared_memory | segment_manager_ |
| std::string | segment_id_ |
| std::size_t | size_ |
| bool | clear_on_destruction_ |
| bool | multiprocess_safe_ |
| shared_memory::Mutex | mutex_ |
Implement a shared array stored on a shared memory segment.
Items hosted by the array may be of (1) fundamental type (e.g. int, double, char), (2) array of fundamental type (e.g. int[10]); or (3) instances of a class implementing a serializable function (see shared_memory::serializer).
| shared_memory::array< T, SIZE >::array | ( | std::string | segment_id, |
| std::size_t | size, | ||
| bool | clear_on_destruction = true , |
||
| bool | multiprocess_safe = true |
||
| ) |
| segment_id | should be the same for all array pointing to the same shared memory segment |
| size | : number of elements to be stored by the array |
| clear_on_destruction | if true, the shared memory segment will be wiped on destruction of the array. Note that any other array pointing to this segment may hang indefinitely as a result. If no arrays pointing to the shared memory segment delete the segment, then users are expected to call shared_memory::clear_array. Failing to do so may result in new array pointing to a new memory segment of the same id to hang indefinitely at construction. |
| multiprocess_safe | if false, it is strongly adviced to protect accesses via a shared_memory::Mutex |
|
noexcept |
This array will point to the share memory segment pointed at by other; and will have same value for multprocess_safe and clear_on_destruction.
Warning: even if other.clear_on_destruction is true, the segment memory will not be wiped on the destruction of other. The duty of deleting the shared memory is passed to the new instance, so to speak
|
noexcept |
This array will point to the share memory segment pointed at by other; and will have same value for multprocess_safe and clear_on_destruction.
Warning: even if other.clear_on_destruction is true, the segment memory will not be wiped on the destruction of other. The duty of deleting the shared memory is passed to the new instance, so to speak


MadBid extension {{ctrl.time | date:'H:mm:ss'}}
Delete cache
Select an auction :
--Empty--
Select a bidder :
--Empty--
Constant bid time
Max bid to place
Enable Autobid
Disable Autobid
{{ctrl.selection.auction.remainingTime}} seconds remain
{{ctrl.selection.auction.currentPrice}} euros
{{ctrl.selection.auction.pacingBidderNumber}} pacing bidders
{{ctrl.selection.auction.aggresiveBidderNumber}} aggresive bidders
{{ctrl.selection.auction.sleepyActiveBidderNumber}} sleepy active bidders
{{ctrl.selection.auction.persistentBidderNumber}} active bidders
Ending Pattern detected !!!
Bids
Bidders
Bid Times


?JARDIN
BOTANICO
NACIONAL
"DR.
RAFAEL
M.
MOSCOSO'
SANTO
DOMINGO,
REPUBLICA
DOMINICANA
12071
S
ero
phulariaceae
NO*.
.FAMILIA.
Baeopa
//-
^
^?^?yoejJ
?1.
very
light
lavender;
in
mud
of
basin,
Reprfblica
^ominicana:
Prov.
La
Altagracia*
1
km.
from
Bayahibe
on
road
NW
to
Preaa
deChav<5n
(on
Rio
Chav<5n)
at
junction
with
road
to
Club
Dominicue;
limestone
coral
rock,
shallow
soil,
dry
broadleaf
forest
with
a
small
basin
with
standing
water
and
oozing
mud*
18¡23*N,
68¡51'W,
alt.
4
10
m.
March
30,
1981.
T.
Zanoni,
M.
Mejia,
C.
Ramirez.
01334140
Legend -
Level of confidence that token is an accurately-transcribed word
extremely low
very low
low
undetermined
medium
high
very high


Home
Menu
Delivery
About
Welcome to Julius Ceasar's Pizza!
Small
10$
Medium
12$
Large
15$
Name:
Last Name
Address
Submit
Your Delivery Details:
First name:
Last Name:
Address:
Small
10$
Medium
12$
Large
15$
Choose your Pizza!
Small
Medium
Large
No Cheese
Average
Extra Cheese
BBQ Sauce
Traditional Tomato Sauce
Alfredo
Chicken
Pepperoni
Bacon
Order Now!
Your Total Will Be:


GameObject and Component Extensions¶
These extensions are quality of life features for Components and GameObjects. Currently there are only a few extensions, but in the future more features will make their way into Nut Library. These extensions are chainable.
Overview¶
Other Extensions
Get Help
EXTENSIONS¶
bool CompareParent(GameObject/Component other)¶
Compares the parents of both objects and returns true if they match eachother.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 | using NutTools;
using UnityEngine;
public class MyClass: MonoBehaviour
{
public GameObject obj;
void MyMethod()
{
if (this.CompareParent(obj))
{
// Do stuff…
}
}
}
|
Parent, Unparent, and SetActive¶
There are many variations of these extensions. They are chainable, as can be seen in the example below.
Parent(Transform parent) - Sets the object’s parent to «parent».
Unparent() - Sets the object’s parent to the scene of the root, which is essentially «null».
SetActive(bool state) - Component-only. Sets the component’s GameObject’s active state.
ParentAndSetActive(Transform parent, bool state) - Sets both the object’s parent and active state.
UnparentAndSetActive(bool state) - Sets the object’s parent to «null» and the active state to «state».
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 | using NutTools;
using UnityEngine;
public class MyClass: MonoBehaviour
{
public GameObject obj;
public Transform parent;
void MyMethod()
{
obj.Parent(parent);
this.Unparent(); // "this" is a component in this case (MyClass), so it's also possible to use extensions like this.
obj.ParentAndSetActive(transform, false);
obj.UnparentAndSetActive(true);
parent.SetActive(true); // Transform is a component as well, so it's possible to call SetActive on it too.
this.SetActive(false)
.Parent(parent); // Chained command example.
}
}
|
GET HELP¶
Join this Discord server to get help, suggest new features, and vote on future updates!
See also
Array and List Extensions
GameObject and Component Extensions
Physics Extensions
Value Extensions
Transform.SetParent()
GameObject.SetActive()


DYNAMICS OF A THETA PINCH DISCHARGE IN A TRANSVERSE MAGNETIC FIELD
by
WILLIAM LEUNG LEE B.Sc., University of Washington, 1960 M.Sc., University of Purdue, 1962
A THESIS SUBMITTED IN PARTIAL FULFILMENT OF THE REQUIREMENTS FOR THE DEGREE OF
DOCTOR OF PHILOSCPHY
in the Department of PHYSICS
We accept this thesis as conforming to the
required s da
THE UNI ITY OF BRITISH COLUMBIA April, 1966
!
{© William Leung Lee 1966 |
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.


Input Types : VectorType
Output Types : VectorType
Date : 28 Feb 2001
The unit called XValues accepts any VectorType input data set and outputs a VectorType containing the x-values associated with the data set, i.e. the values that are used in the internal storage as the independent variable of the data set.
XValues has no parameter window.


By jadedResearcher. Special thanks to paradoxLands for additional coding (especially the ability to save and load to images), and to karmicRetribution (for user testing).
Knowledge gained from:
Weaving 2/1 Twill on a Rigid Heddle Loom, by Sylvia Emard on her blog "I Dyed it My Way"
Inventive Weaving on a Little Loom, by Syne Mitchell
Weaving on 3 shafts, by Erica de Ruiter
A v1, non rigidHeddle specific version of this tool can be found
here.
* Note: Any pattern that only goes UP or NEUTRAL in the second heddle can be replicated via a single pickup stick.


Workflows¶
This guide is a resource for using the Blue Sky Workflow Engine package. It is maintained by the Allen Institute for Brain Science.
The Blue Sky Workflow Engine is designed for creating new workflows to manage and orchestrate projects.
Workflow YAML Format¶
Workflows can be specified in a YAML syntax document. A workflow file has three top-level sections: executables, run_states (deprecated) and workflows.
Executables¶
The pbs_processor and pbs_walltime entries are directives that are used in creating a qsub script.
executables:
mock:
name: 'Mock Executable'
path: '/path/to/bin/on/hpc/cluster/mock_executable'
remote_queue: 'pbs'
pbs_queue: 'project_queue_name'
pbs_processor: 'nodes=1:ppn=1'
pbs_walltime: 'walltime=0:10:00'
Run States¶
Note
The run_states section is deprecated. Leave it verbatim as below for now.
run_states:
- "PENDING"
- "QUEUED"
- "RUNNING"
- "FINISHED_EXECUTION"
- "FAILED_EXECUTION"
- "FAILED"
- "SUCCESS"
- "PROCESS_KILLED"
Workflows¶
The workflows section describes the JobQueue objects and their corresponding WorkflowNode objects arranged in a Workflow object.
The workflows element has a sub element with a key for each workflow (in this case ‘mock_workflow’ is the only one). Under the workflow key is an optional ‘ingest’ strategy, a list of ‘states’ and a ‘graph’ of the relation between the states.
Note
The ‘states’ roughly correspond to the JobQueue and WorkflowNode objects in the Django model. The graph represents the parent relationship between WorkflowNodes.
Each workflow has an ‘ingest’ element with the name of an ingest strategy. The ingest strategy accepts a JSON message from an upstream client external to the workflow and creates Django model objects. For workflows that process objects that have already been created by another workflow or via the admin UI an ingest strategy is not needed.
The ‘states’ element contains a list of entries for JobQueues and WorkflowNodes. For each entry, a JobQueue will be created with the specified ‘class’, ‘executable’ and ‘enqueued_class’
The ‘graph’ element contains a list of lists to specify the parent child relationship. The ‘key’ of the parent node is followed by a list for the children.
Warning
There are known issues with the graph representation. It is currently best to list the nodes roughly in order. Multiple parents cannot currently be represented, but the import code may not log an error.
workflows:
mock_workflow:
ingest: "blue_sky.strategies.mock_ingest.MockIngest"
states:
- key: "ingest_mock"
label: "Ingest Mock"
class: "blue_sky.strategies.mock_ingest.MockIngest"
enqueued_class: "blue_sky.models.observation.Observation"
executable: "mock"
- key: "mock_analyze"
label: "Mock Analyze"
class: "blue_sky.strategies.mock_analyze.MockAnalyze"
enqueued_class: "blue_sky.models.observation.Observation"
executable: "mock"
graph:
- [ "ingest_mock", [ "mock_analyze" ] ]
Reloading the Workflow¶
There is a custom Django management command for reloading the workflows from a yaml file.
$ python -m manage import_workflows path/to/workflow_file.yml
Warning
Reloading the workflows currently does a cascading delete on all job records.
Editing a Workflow in the Admin UI¶
A job queue may be added to a workflow or modified using the Django Admin UI. Under the workflow_engine section, first add an executable. Then add a job_queue that references the executable. Finally add a workflow node. Assign it to a workflow and set the parent node. You can then access the new node in the workflow view or on the workflow admin page.
Note
There is currently no way to export a yaml file when the workflow has been edited using the admin UI.


def forward(self, img):
out = self.feature_extractor(img)
print (out.shape)
out = self.fc(out)
return out
def forward(self, img):
out = self.feature_extractor(img)
out = out.view(out.size(0), -1)
out = self.fc(out)
return out


Are you tired of grepping /usr/include to figure out what that system error number means? Here's a handy guide to all the errno values for your system. Use your browser search functionality to find the one you're looking for or just scroll down the table.
You are viewing the error codes for $osName; if you want to view the error codes for a different operating system, select it from the dropdown menu.
$html
To load the error information as JSON, use:
$path/$osId/json
$json
For JSONP, add a callback value as a query parameter:
$path/$osId/json?callback=myCallback


This project includes the entire process followed for the design and construction of a prototype seedbed with environmental control for the cultivation of horticultural species during its early stages of development.
The creation of the prototype, the different necessary electronic components, the communication infrastructure between the different devices, the necessary programming code, and the creation of a user interface to view the collected data will be discussed.
The project has been carried out in a self-taught way thanks to the material provided by the Library of the Carlos III University of Madrid and consultations made with professors and acquaintances who carry out their professional work in the agriculture sector, under the supervision of my tutor from the TFG.
Javascript
Node js - Express
Materialize HTML5
Firebase
Arduino
MQ-135
LDR
DHT22
Capacity moisture sensor v2.0
Thanks to the Firebase ICloud platform, data can be displayed in dynamic charts using its Realtime Database utility.
Alert when irrigation is activated by sending a notification of a text message thanks to the Twilio platform.
Thanks to the Open Source environment and platforms of Arduino and Raspberry Pi you can implement any imaginable functionality
DiY projects!!
Stay on top of my projects and find all the documentation in my Github repository
For more information I will be happy to answer through my personal email.
Temperature
Loading...
%
humidity
Loading...
%
humidity ground
Loading...
%
CO2
Loading...
ppm
LDR
Loading...
lux


Given the global scale of plastic pollution, the cost of removing plastics from the environment would be prohibitive. Most solutions to the problem of plastic pollution, therefore, focus on preventing improper disposal or even on limiting the use of certain plastic items in the first place.
Most of the developing nations do not have the resources to handle their plastic waste effectively. These countries have experienced massive booms in plastic manufacturing, but the required infrastructure to effectively manage the waste doesn’t exist or is poor. Lending support to these countries and helping them build up their infrastructure could be a huge help in reducing the amount of plastic in the oceans.
At an individual level, the best thing we can do to protect our waterways is try to keep as much plastic as possible out of the waste stream in the first place.
About 1 million plastic bags are used every minute, and a single plastic bag can take 1,000 years to degrade. If you’re already bringing reusable bags to the grocery store, you’re on the right track, but if you’re still using plastic produce bags, it’s time to make a change.
Reduce your use of plastics, reuse plastic products whenever possible, recycle all of the rubbish you can!
These small plastic beads are found in some facial products, soaps, shower gels and toothpastes. They are very small so can’t be effectively filtered from waste before it enters rivers, lakes or oceans.
Bottled water produces 1.5 million tons of plastic waste per year, and these bottles require 47 millions gallons of oil to produce, according to Food & Water Watch. Bring a reusable cup to coffee shops and ask the barista to fill it up, and keep a mug at your desk instead of using plastic cups.
REDUCE YOUR PLASTIC FOOTPRINT
Plastic baggies, plastic wrap, and plastic storage containers are worth re-evaluating. Instead of sandwich baggies, why not pack a tiffin for lunch? When it comes to carryout, these types of containers be used instead of disposable ones—although it can definitely take a bit of courage and some explaining to help your local restaurants to understand.
Single-serving yogurts, travel-size toiletries, tiny packages of nuts—consider the product-to-packaging ratio of items you tend to buy often and select the bigger container instead of buying several smaller ones over time.
Write to your legislator for setting up the environmental protection policies, especially on plastic wastes!
One of the ways you can help marine and beach animals escape the dangers of plastics is by litter-picking. Make beach cleanups a family event! Spread the word. Talk to your family and friends about why it is important to rise above plastics.
Source: Tele-Visual Infolink


Gecode::Int::Element::IdxValMap Class Reference
List of all members.
Detailed Description
Class for index-value map.
Definition at line 160 of file int.icc.
|
Public Member Functions |
| template<class ViewA> |
| void | init (int *, ViewA) |
| template<class ViewA> |
| void | prune_idx (ViewA) |
| | Pruning from variables on data structure.
|
| template<class ViewB> |
| void | prune_val (ViewB) |
| template<class ViewA, class ViewB> |
| ExecStatus | tell (Space *, ViewA, ViewB) |
| | Telling data structure to variables: returns true if at fixpoint.
|
| size_t | size (void) const |
Static Public Member Functions |
| static IdxValMap * | allocate (int) |
| | Allocating and initializing the data structure.
|
| static void | operator delete (void *p, size_t) |
Member Function Documentation
| IdxValMap * Gecode::Int::Element::IdxValMap::allocate |
( |
int |
|
) |
[inline, static] |
|
|
|
Allocating and initializing the data structure.
Definition at line 194 of file int.icc. |
|
template<class ViewA> |
| void Gecode::Int::Element::IdxValMap::init |
( |
int * |
, |
|
|
ViewA |
|
|
) |
[inline] |
|
|
template<class ViewA> |
| void Gecode::Int::Element::IdxValMap::prune_idx |
( |
ViewA |
|
) |
[inline] |
|
|
|
Pruning from variables on data structure.
Definition at line 242 of file int.icc. |
|
template<class ViewB> |
| void Gecode::Int::Element::IdxValMap::prune_val |
( |
ViewB |
|
) |
[inline] |
|
|
template<class ViewA, class ViewB> |
| ExecStatus Gecode::Int::Element::IdxValMap::tell |
( |
Space * |
, |
|
|
ViewA |
, |
|
|
ViewB |
|
|
) |
[inline] |
|
|
|
Telling data structure to variables: returns true if at fixpoint.
Definition at line 283 of file int.icc. |
| size_t Gecode::Int::Element::IdxValMap::size |
( |
void |
|
) |
const [inline] |
|
| void Gecode::Int::Element::IdxValMap::operator delete |
( |
void * |
p, |
|
|
size_t |
|
|
) |
[inline, static] |
|
The documentation for this class was generated from the following file:


WITNESS LIST
Public Health Committee
April 11, 2012 - 10:30 AM
Charge #2: State Health Registries and Databases
On:
Belcher, Nora (Texas e-Health Alliance)
Cardwell, Michael (DSHS)
Cruz, Angel (Dept. of Information Resources)
Dragsbaek, Anna (The Immunization Partnership)
Floyd, Gary (Texas Medical Association Texas Pediatric Society)
Gray, James (American Cancer Society)
Guillory, Charleta (March of Dimes)
Klein, Jorie (THA/ Parkland Health & Hosp. System)
Valadez, Adolofo (TX Dept. State Health Services)
Registering, but not testifying:
On:
Palmer, Stephen (Health and Human Services Commission)
Charge #5: State Board of Dental Examiners
For:
Byrne, Roger (Self)
McDonald, Gary (Self)
Stringfield, Larry (TDR Texans for Dental Reform)
Strunk, George (Self)
Against:
Gruwwald, Pam (Texans for Dental Reform)
Mitchell, Gwen (Texans for Dental Reform)
Moriarty, Jim (Self)
Smith, Lyric (Texans for Dental Reform)
Sonnier, Leo (Texans for Dental Reform)
Stankewitz, Mark (Texans for Dental Reform)
Terry, Douglas (TDR)
Tran, Kevin (Texans for Dental Reform)
On:
Black, Rick (Texas Dental Association)
Cazares, Jose (Texas Academy of General Dentistry)
Gough, Tammy (TSBDE)
Gustin, Charlie (The Crosley Law Firm)
Hughes, Renee (Self)
Hughes, Tom (Self)
Jones, Lisa (State Board of Dental Examiners)
Murphy, Becky (Self)
Paoloski, Susana (Self)
1
WITNESS LIST
On:
Parker, Glenn (Texas State Board of Dental Examiners)
Sparks, Joy (TSBDE)
Zalud, Lucille (Self)
Registering, but not testifying:
On:
Ukeiley, Robert (Self)
2


| S.No. | Invoice No | Invoice Date | Sales Amount | Return Amount | Net Amount | |
|---|---|---|---|---|---|---|
| {{j+1}} | PH{{row.InvoiceNo}} |
|
{{row.SalesAmount}} | {{row.ReturnAmount}} | {{row.NetAmount}} |
There is no pending credit invoices for this patient.
Please proceed for provisional (if any) or Deposit Refund.
| Total Credit Amount: | |
| Discount On Settlement: |
Discount amount is invalid. |
| Payable Amount: | |
| Deposit Available: | |
| Amount To Pay: | |
| Amount To Return: | |
| ( In words: {{ model.PaidAmount | NumberInWords}} only ) ( In words: {{ model.RefundableAmount | NumberInWords}} only ) |
| Provisional Amount : | 0}"> {{ProvisionalInfo.ProvisionalTotal}} 0"> Generate Invoice |


First of all, thank you for spending your time participating in our user study. It should not take longer than 10 minutes to complete. Please, read carefully the instructions before you proceed with the survey.
How to do the task
In order to accomplish the following task successfully, you will have to imagine that you are designing a graphical user interface where you need to place a group of icons. You already have placed the Reference icon and you need
to place another one whose style is visually similar to the style of the Reference. Your task now is to select the image which matches best with the Reference. In some cases, neither A nor B will seem visually similar to
the Reference, in this scenario try to make the best choice you can.
Selection example
Before you begin the survey, we will show you two basic examples of an icon selection task with the answers explained.
- In Example 1, the correct option will be A. Icon A has no contour lines, and it is a solid icon coloured with black colour, exactly as the Reference. The icon B is not a solid icon and it has a medium-thick contour line, not
matching in style with the Reference. Icon B and the Reference have the same arrow shape, but this survey is focusing on style, consequently the shape should not affect the decision.
- In Example 2, the correct option will be A. The icon A has a thin contour line and it is not a solid icon, sharing these style properties with the Reference. The icon B is not solid but its contour lines are really thick which
is the opposite to the Reference's contour lines.
Some data about you
Gender
Knowledge in Graphical User Interfaces:
Knowledge in Graphical Design:
That's all folks
Please note that javascript should be enabled for the survey to work correctly.
Remember that the figures we have shown below are just simple examples and the different cases that you will see displayed during the test may
vary and be more complicated.
Press START to begin the survey.
/
Let's start the training
This is how the survey user interface will look like.
In case you didn't read the instructions yet, we encourage you to read them before doing the training part.


Stimulus
Detection Using Neuro-Imaging
The Primary objective of this project is to understand and analyze various experiments conducted on
brain fMRI images so as provide a deep understanding of human brain. This helps us in understanding, the
working of our brain and also helps in detecting and providing solutions to health problems related to
brain such as brain tumour.


If you don't want to configure the SDK with environment variables or you want more fine grained control over the
instance, you can create an instance yourself and use the handlers and helpers from that.
First, export your configured instance from another module:
Configuration properties.
The Server part of the SDK can be configured in 2 ways.
1. Environmental Variables
The simplest way to use the SDK is to use the named exports (HandleAuth, HandleLogin, HandleLogout, HandleCallback, HandleProfile, GetSession, GetAccessToken, WithApiAuthRequired and WithPageAuthRequired), eg:
When you use these named exports, an instance of the SDK is created for you which you can configure using environmental variables:
Required
AUTH0_SECRET
: See secretAUTH0_ISSUER_BASE_URL
: See issuerBaseURLAUTH0_BASE_URL
: See baseURLAUTH0_CLIENT_ID
: See clientIDAUTH0_CLIENT_SECRET
: See clientSecretOptional
AUTH0_CLOCK_TOLERANCE
: See clockToleranceAUTH0_HTTP_TIMEOUT
: See httpTimeoutAUTH0_ENABLE_TELEMETRY
: See enableTelemetryAUTH0_IDP_LOGOUT
: See idpLogoutAUTH0_ID_TOKEN_SIGNING_ALG
: See idTokenSigningAlgAUTH0_LEGACY_SAME_SITE_COOKIE
: See legacySameSiteCookieNEXT_PUBLIC_AUTH0_LOGIN
: See NextConfig.routesAUTH0_CALLBACK
: See BaseConfig.routesAUTH0_POST_LOGOUT_REDIRECT
: See BaseConfig.routesAUTH0_AUDIENCE
: See BaseConfig.authorizationParamsAUTH0_SCOPE
: See BaseConfig.authorizationParamsAUTH0_ORGANIZATION
: See NextConfig.organizationAUTH0_SESSION_NAME
: See SessionConfig.nameAUTH0_SESSION_ROLLING
: See SessionConfig.rollingAUTH0_SESSION_ROLLING_DURATION
: See SessionConfig.rollingDurationAUTH0_SESSION_ABSOLUTE_DURATION
: See SessionConfig.absoluteDurationAUTH0_COOKIE_DOMAIN
: See CookieConfig.domainAUTH0_COOKIE_PATH
: See CookieConfig.pathAUTH0_COOKIE_TRANSIENT
: See CookieConfig.transientAUTH0_COOKIE_HTTP_ONLY
: See CookieConfig.httpOnlyAUTH0_COOKIE_SECURE
: See CookieConfig.secureAUTH0_COOKIE_SAME_SITE
: See CookieConfig.sameSite2. Create your own instance using InitAuth0
If you don't want to configure the SDK with environment variables or you want more fine grained control over the instance, you can create an instance yourself and use the handlers and helpers from that.
First, export your configured instance from another module:
Then import it into your route handler:
Note If you use InitAuth0, you should not use the other named exports as they will use a different instance of the SDK.


Last updated on: May 8, 2017
Format
- U1800 is divided into a preliminary phase (round robin)
and a final phase.
- In the preliminary phase, players can play with anyone
who registered for this tournament. Winner gets 2 points, and
the losing player gets 1 point. No matches between guest
players.
- Playoff round will take 16 players. Based on the score
from first round, top 16 ranked plays will be advance to the
play off round. If there is no female player in top 16, then
take top 16, the 16th seat will be given to the first ranked
female player. If there is a tie, use Winning Ratio as the tie
breaker.
- The playoff round is temporarily defined as single
elimination.
Eligibility
- USATT tournament rating or league rating less than 1800 is qualify
for players, else can participate as guest players. Organizers
can assign a rating to unrated players.
- If a player
has both USATT tournament rating and league rating, use the
later rating before April 5, 2017
- No matches between guest players. Guest player will not
be eligible for playoff round
- Please register at http://goo.gl/iD8Z5s
Awards
- Champion: $50 + medal
- Runner up: $20 + 2 box Nittaku premium plastic balls + medal
- Third and fourth place: 2 box Nittaku premium plastic balls
- The rest Final qualifiers: 1 box Nittaku premium plastic balls
- The best Guest player: 2 box Nittaku premium plastic balls
Schedule
- Apr 5 - 18：Registration
- Apr 19 - May 31: preliminary phase
- Jun 3: U1800 playoff & final


DOAG |
|
Type body call_stack_type |
| Program units |
| pause | |
| resume | |
| leave | |
| call_stack_type |
pause
Procedure pause
resume
Procedure resume
leave
Procedure leave
call_stack_type
Function call_stack_type(self in out nocopy call_stack_type, id in number, session_id in varchar2, user_name in varchar2, module_name in varchar2, method_name in varchar2, params in msg_params, call_level in integer, trace_timing in char) return self as result


| Total net profit | -625.73 | Gross profit | 676.59 | Gross loss | -1302.32 |
| Profit factor | 0.52 | Expected payoff | -4.14 | ||
| Absolute drawdown | -633.38 | Maximal drawdown (%) | 596.0 (-1594.44%) | ||
| Total trades | 151 | Profit trades (% of total) | 64 (42.38%) | Loss trades (% of total) | 87 (57.62%) |
| Long positions (won %) | 62 (46.77%) | Short positions (won %) | 89 (39.33%) | ||
| Largest | profit trade | 32.98 | loss trade | -38.63 | |
| Average | profit trade | 10.57 | loss trade | -14.97 | |
| Minimum | profit trade | 1.05 | loss trade | -1.34 | |
| Maximum | take profit in pips | 2620.0 | stop loss in pips | -3250.0 | |
| Average | take profit in pips | 925.1 | stop loss in pips | -1361.6 | |
| Minimum | take profit in pips | -110.0 | stop loss in pips | -200.0 | |
| Maximum | Reward-Risk | 5.5 | Duration in minutes | 3270 | |
| Average | Reward-Risk | 0.9 | Duration in minutes | 142.6 | |
| Minimum | Reward-Risk | 0.0 | Duration in minutes | 0 | |
| Maximum | consecutive wins (profit in money) | 5.0 (65.24) | consecutive losses (loss in money) | 5.0 (-99.35) | |
| Average | consecutive wins | 1.0 | consecutive losses | 2.0 |
| Total net profit | -315.4 | Gross profit | 241.88 | Gross loss | -557.28 |
| Profit factor | 0.43 | Expected payoff | -5.09 | ||
| Absolute drawdown | -315.4 | Maximal drawdown (%) | 289.49 (-1117.29%) | ||
| Total trades | 62 | Profit trades (% of total) | 29 (46.77%) | Loss trades (% of total) | 33 (53.23%) |
| Largest | profit trade | 19.91 | loss trade | -31.03 | |
| Average | profit trade | 8.34 | loss trade | -16.89 | |
| Minimum | profit trade | 1.05 | loss trade | -1.34 | |
| Maximum | take profit in pips | 1930.0 | stop loss in pips | -3250.0 | |
| Average | take profit in pips | 721.1 | stop loss in pips | -1601.9 | |
| Minimum | take profit in pips | -110.0 | stop loss in pips | -270.0 | |
| Maximum | Reward-Risk | 3.2 | Duration in minutes | 968.0 | |
| Average | Reward-Risk | 0.6 | Duration in minutes | 107.0 | |
| Minimum | Reward-Risk | 0.0 | Duration in minutes | 0.0 | |
| Maximum | consecutive wins (profit in money) | 4.0 (24.71) | consecutive losses (loss in money) | 5.0 (-78.04) | |
| Average | consecutive wins | 2.0 | consecutive losses | 2.0 |
| Total net profit | -310.33 | Gross profit | 434.71 | Gross loss | -745.04 |
| Profit factor | 0.58 | Expected payoff | -3.49 | ||
| Absolute drawdown | -386.95 | Maximal drawdown (%) | 349.57 (-935.18%) | ||
| Total trades | 89 | Profit trades (% of total) | 35 (39.33%) | Loss trades (% of total) | 54 (60.67%) |
| Largest | profit trade | 32.98 | loss trade | -38.63 | |
| Average | profit trade | 12.42 | loss trade | -13.8 | |
| Minimum | profit trade | 1.58 | loss trade | -2.61 | |
| Maximum | take profit in pips | 2620.0 | stop loss in pips | -2980.0 | |
| Average | take profit in pips | 1067.2 | stop loss in pips | -1194.2 | |
| Minimum | take profit in pips | 120.0 | stop loss in pips | -200.0 | |
| Maximum | Reward-Risk | 5.5 | Duration in minutes | 3270.0 | |
| Average | Reward-Risk | 1.1 | Duration in minutes | 167.4 | |
| Minimum | Reward-Risk | Duration in minutes | 0.0 | ||
| Maximum | consecutive wins (profit in money) | 4.0 (60.05) | consecutive losses (loss in money) | 5.0 (-99.35) | |
| Average | consecutive wins | 1.0 | consecutive losses | 2.0 |


THE FIRM A film review by David N. Butterworth Copyright 1993 David N. Butterworth/The Summer Pennsylvanian
"I want the truth!" demands hotshot lawyer Tom Cruise in last year's military drama, A FEW GOOD MEN. And in his new film, THE FIRM, Cruise once again plays a hotshot lawyer who's searching for the truth. Talk about a stretch! Actually, Cruise's character Mitchell McDeere stumbles upon the truth fairly quickly in the film. But unfortunately for him and THE FIRM, dealing with the unsavory aspects of that truth produces more fizzle than sizzle.
Okay. So Tom's this red-hot Harvard Law School grad who, as the film opens, is being courted by all these prestigious law firms. But Cruise's Mitch is astute and won't take any old offer. He wants the best. He's got a mother in a trailer park and an estranged brother in the county lockup so he's got something to prove. And he wants to give his adoring wife Abby (the cozy bathrobe-sporting Jeanne Tripplehorn) more than a mere hand-to-mouth existence. They are young, beautiful people after all. Surely they deserve better than that?
So when the small but prosperous Memphis law firm Bendini, Lambert & Locke make him an offer he can't refuse, well, he can't refuse it.
So. Mitch and Abby U-Haul it down to picture postcard-perfect Tennessee where they're wined and dined by the Firm. Their house is beautiful; it's furnished, carries a low-interest mortgage, and even has a Mercedes in the driveway. But what's most important is that the Firm doesn't forbid its lawyers' wives to work and "encourages children." "How *exactly* do they do that?" questions Abby, with keen-eyed skepticism.
As idyllic as home life should be, the workplace is tough as hell. Nobody's ever failed the bar exam Mitch is told once, twice, one hundred times in a zany montage of mounting legal tomes and dwindling desk space. But before the film gets bogged down in legal pen-pushing... Bang! There's an explosion aboard a yacht in the Grand Caymans where two of the Firm's associates were vacationing. Both killed. "That's four dead lawyers in under ten years," comments a total stranger in a greasy spoon late one night. One of the guys, played by Ed Harris, has a bald head and thick-rimmed glasses and looks like a Fed. "Who are you guys?" asks Mitch, inquiringly, but they've ordered their steak sandwiches *to go*!
Before long, Mitch and his assigned mentor Avery Tolar (Gene Hackman, who's name is inexplicably missing from the film's advertisements) whip down to those treacherous, attorney-claiming islands to bully a client. Because Mitch is a hotshot lawyer, you know it won't be long before he starts getting suspicious. I mean, those boxes of files in Avery's closet with the names of the dead lawyers on them and stuff? Something is definitely up. But Mitch goes overboard on the rum punches one night and partakes of one local delicacy too many, so to speak. Eight-by-ten glossies in a brown manila envelope to follow.
In the nation's capital, Agent Tarrance (Harris) pops up again and we get the low-down on Mitch's employers. (C'mon... All that's missing from the film's title is the word "unscrupulous.") But what the government needs is proof. Incriminating evidence of the documentary kind. What they need is for some hotshot lawyer to make photocopies and stuff so that they can put the whole lousy stinking operation away for a long, long time. Mitch says "No way!" But he sleeps on it and comes up with a scam involving $1.5 million, a Swiss bank account, and the early release of his brother-the-convict. Takes a real hotshot to rip off the Federal Bureau of Investigation!
THE FIRM is never boring (even at almost 2 hours and 40 minutes) but it never really sparkles either. Sure there's some tension, but McDeere's plan to bring the Firm to its knees (which even his *wife* doesn't want to hear about) isn't exactly awe-inspiring. And the denouement, which was changed from novelist John Grisham's original ending, requires a humongous stretch of the imagination.
The acting, much as you would expect from this cast, is uniformly solid. Gary Busey plays private eye Eddie Lomax who buys it with style. Blam! Pow! Holly Hunter plays his gum-chewing secretary Tammy Hemphill who was under the table giving him a "pedicure." David Strathairn sensitively portrays Mitch's incarcerated brother, Ray. Hal Holbrook is the Firm's senior partner Oliver Lambert, and Wilford Brimley its tough head of security who's "paid to be suspicious."
Similarly, Sydney Pollack's direction is competent and workmanlike. The script, adapted from Grisham's bestseller, was pulled together by David Rabe, Robert Towne (who wrote CHINATOWN), and David Rayfiel. But the feeling you get from all their efforts is just one more humdrum movie-going experience.
If the thought of another Tom Cruise hotshot still turns you on, then THE FIRM is definitely for you. But if you're more interested in a slick, engrossing tale of corporate corruption, read the hardcopy version instead.
.
The review above was posted to the
rec.arts.movies.reviews newsgroup (de.rec.film.kritiken for German reviews).
The Internet Movie Database accepts no responsibility for the contents of the
review and has no editorial control. Unless stated otherwise, the copyright
belongs to the author.
Please direct comments/criticisms of the review to relevant newsgroups.
Broken URLs inthe reviews are the responsibility of the author.
The formatting of the review is likely to differ from the original due
to ASCII to HTML conversion.
Related links: index of all rec.arts.movies.reviews reviews


union-pacific
Businessmodel of Union Pacific
Customer Segments
Union Pacific has a mass market business model, with no significant differentiation between customer segments. The company targets its services at firms in almost any industry that need to transport their goods. That said, its customers can most commonly be found in the agricultural products, automotive, chemicals, coal, and industrial products sectors.
Value Proposition
Union Pacific offers three primary value propositions: accessibility, risk reduction, and brand/status.
The company creates accessibility by offering a wide variety of options. It provides transportation services for one of the most diversified ranges of commodities in the industry, including chemicals, coal, consumer products, food and food products, forest products, grain and grain products, government, intermodal, metals, minerals, waste, and automobiles and parts.
The company reduces risk by maintaining high safety standards. It has developed and is in the process of implementing its Positive Train Control (PTC) system, which involves multiple technologies working together to manage and monitor train movements. The technologes include GPS, antennas, satellites, locomotive and base station radios, and telecom and signal elements. Thus far, the company has equipped over 3,200 locomotives with the system. Union Pacific also reduces risk by having strong security measures. It maintains a comprehensive security plan that features four levels of alert status, each with countermeasures. It also operates its own force of over 250 police officers.
The company has established a powerful brand due to its success. It has the largest railroad network in the United States, with its franchise covering 23 states across the western two-thirds of the country. It serves several of the fastest-growing U.S. population centers, operates from all major Gulf Coast and West Coast ports to eastern gateways, connects with Canada’s rail systems, and is the only railroad serving all six major Mexico gateways. It serves 10,000 customers and operates the largest diesel-electric fleet in the country. Lastly, it has won many honors, including the following:
- Recognition as one of 100 Most Trustworthy Companies In America by Forbes
- Recognition as one of America’s Best Employers by Forbes
- Recognition as one of Fortune’s Most Admired Companies
- Recognition as one of Military.com‘s 2016 Best Companies for Veterans
- The Logistics Excellence Awards from Toyota Logistics Services ### Channels
Union Pacific’s main channel is its direct sales team, which is divided into six groups based on commodities. The company promotes its offering through its website and social media pages.
Customer Relationships
Union Pacific’s customer relationship is primarily of an automated nature. The company provides its services without a need for significant interaction with customers.
That said, it does offer the option of a dedicated Shipment Quality team and an Industrial Development group, which offer specialized services involving site and location analysis for business development.
Key Activities
Union Pacific’s business model entails designing, developing, and delivering its services to customers.
Key Partners
Union Pacific’s key suppliers are two unspecified domestic firms that provide it with high horsepower locomotives. It also utilizes two steel producers (one domestic, one international) for a large percentage of its rail purchases, as well as suppliers for fuel and various materials and services.
The company’s website features a section called “Supplier Resources” that includes helpful tools, including an eBusiness glossary, a “Supplier Excellence Manual”, and answers to common questions.
Key Resources
Union Pacific’s main resources are its physical resources, the most important of which is its rail network, which includes 32,084 route miles (it owns 26,064 miles and operates on the rest through trackage rights or leases). It also depends on its collection of over 8,500 locomotives and over 66,863 freight cars.
Moreover, it operates the Harriman Dispatching Center, its primary dispatching facility, in Omaha, Nebraska. Lastly, it depends on train drivers and customer service personnel.
Cost Structure
Union Pacific has a cost-driven structure, aiming to minimize expenses through significant automation. Its biggest cost driver is compensation/benefits for staff. Other major drivers are cost of services and materials, cost of fuel, and cost of equipment, all variable expenses.
Revenue Streams
Union Pacific has two revenue streams:
- Freight Revenues – Revenues generated through fees paid by customers for the transport of freight or other materials. Sales vary with volume (carloads) and average revenue per car (ARC).
- Other Revenues – Include revenues generated by subsidiaries, from commuter rail operations, accessorial revenues (earned when customers retain equipment owned or controlled by Union Pacific or when it performs extra services such as storage or switching), and miscellaneous contract revenues.


Sometimes, films can catch you off guard. And one way to do that is to make it look like the film has melted from the projector. This doesn't just happen in the films, this can happen on television, cartoons, heck, even webtoons! Just don't expect to be caught off guard if it's in a video or cartoon on the internet.
See Born in the Theatre for a broader trope dependent on the idea that one is watching film in a theater.
Examples:
open/close all folders
Film
- Cinema Paradiso actually shows a film that's being projected melting on the screen, just before it disastrously catches fire. Of course we're talking about nitrate film here, pre-safety stock.
- Happens in the Animated Credits Opening of The Great Race.
- Happens on Gremlins 2: The New Batch, when the Gremlins appear to take over the theater projector. On the home video version, the VHS glitches out instead.
- Halfway through The Muppet Movie, the film melts. It takes a few moments before the Swedish Chef has things going again.
- Persona directed by Ingmar Bergman might be the Trope Maker here (or, at least, the Trope Codifier).
- Planet Terror: Happens during the reel changes.
- An In-Universe example is seen in The Smallest Show on Earth, a film about a couple running a broken-down old cinema in the north of England.
- Midnight Movie: The effect is used in universe in a chilling way. None of the scenes straight after it happens are from the film they're watching.
- The 1971 cult film classic Two-Lane Blacktop uses this trope to bring the movie to a disjointed end. The audience is placed in the back seat of a suped-up 55 Chevy in a drag race at a track, looking forward over the shoulder of the driver (James Taylor). Just before the car accelerates down the track the sound drops out and as the car picks up speed the film slows until it starts to melt through and then the screen goes to black. The audience never sees the end of the last race.
- Mystery Science Theater 3000: The Movie: Dr. Forrester accidentally does this to This Island Earth.
- At the end of the 1968 Monkees film Head, a grand and beautiful version of the Columbia Pictures torch lady fades in. As the ending orchestral theme blasts on, the film begins to flutter increasingly on the logo, wriggles around and slides wildly until it stablizes again; to a complete jammed stop it seems as the film begins to melt away to the top-left corner upon a background of flames, and is only just a little black shrivel when the lens finally shuts. It is not known whether this was intentionally done to end the movie on a distinctive note, or this accidentally happened and became a Throw It In! moment.
Live-Action TV
- M*A*S*H: In-Universe, while the characters are having a film night (they're watching My Darling Clementine), the projector jams up and Klinger has to fix it. To keep themselves entertained while waiting for him, they have a sing-along and impressions contest.
Music
- Ultravox's "Dancing With Tears In My Eyes" video ends with the family's Happier Home Movie film melting, presumably due to nuclear radiation.
- As part of Godspeed You! Black Emperor's live show, they have visuals projected from actual film. Later in the show, the projectionist will literally burn the film (with a lighter) while it's still being shown, producing this effect.
Web Original
- The beginning of the Unskippable intro sequence, but only in the archives, as the more recent ones just have the Escapist's logo.
- Homestar Runner: Used in a music video for "Experimental Film" by They Might Be Giants. According to the in-character commentary, it happened because Strong Sad loaded the film wrong, and he decided to Throw It In!.
Web Videos
- Part of Honest Trailers's opener seen Once per Episode.
Western Animation
- Monsters vs. Aliens begins with the Dreamworks Animation title melting away, revealing the real film beneath. Especially effective on 3-D.
- In My Little Pony: Friendship Is Magic, one of Granny Smith's long-ago flashbacks in "Leap of Faith" ends this way.
- Used on Kick Me as a Deus ex Machina to save the main character from a Giant Spider.


Salmon Cookies Sales Page
Enter New Store Values
Store Name
Min Customer
Max Customer
Average Cookies Per Sale
Create
Reset
Home Page


We are conducting a world-wide scientific study to assess the possible relationships between respiratory illness (e.g., COVID-19, influenza or the common cold) and their effects on smell & taste
To learn more and to participate in the study, click the survey button below.
English Deutsch Español Français ItalianoIn response to anecdotal reports of the loss of smell and of taste in people who have tested positive for COVID-19, a group of international smell and taste researchers have united to study how, when and why this is happening and what it can tell us about the Coronavirus.
This inclusive group, called The Global Consortium of Chemosensory Researchers (GCCR), consists of open-science contributors: transdisciplinary scientists, clinicians, and patient advocates from all over the world.
Because the systems of smell and taste are related, so are the symptoms of loss of these senses. Yet the loss of the sense of smell after a virus, such as a common cold, affects many people, whereas the loss of the sense of taste is reported much less frequently.
The GCCR wants to know if smell loss is a frequent symptom of the Coronavirus and if it is accompanied by taste loss.
The GCCR will foster the advancement of chemosensory science at large, allowing the possibility to test larger samples of participants cross-culturally, strengthening the reliability and validity of chemosensory science across many domains.
Currently, the timely mission of the GCCR is to define and coordinate world-wide crowdsourced research to understand the reports of the chemosensory issues related to COVID-19. Subsequently, the establishment of this consortium.
In accomplishing this mission, the GCCR’s primary roles are to work cooperatively with its members to:
Encourage and facilitate global collaboration in concert with local collaboration across countries, labs, scientists and clinicians interested in the chemical senses.
Encourage and facilitate the implementation of open science practices the GCCR projects will allow the members as well as the community at large to access protocols and data.
Encourage and facilitate the development and dissemination of new knowledge by authoring papers based on the core data collected by the GCCR as a group.
please feel free to send us an email at contact.gccr@gmail.com


ph2_single_bayes_seq_sim.Rd
Trial is a single arm Bayesian phase 2 trial with sequential stopping boundaries as outlined in Thall, Peter F., and Richard Simon. "Practical Bayesian guidelines for phase IIB clinical trials." Biometrics (1994): 337-349.
ph2_single_bayes_seq_sim( omega_s_mu, omega_s_width, omega_s_w_conf_level = 0.9, omega_e_c, delta_0, n_min, n_max, sim_n = 1, pr_low = 0.05, pr_high = 0.95, mu_e = omega_s_mu + delta_0, verbose = FALSE, quiet = FALSE )
| omega_s_mu | Mean of prior distribution on omega_s |
|---|---|
| omega_s_width | Width of the probability interval (set by |
| omega_s_w_conf_level | Confidence level of width of probabilty specified |
| omega_e_c | Concentration parameter for prior distribution on omega_e |
| delta_0 | Targeted improvement of treatment for treatment E over S |
| n_min | Minimum number of patients that may be enrolled |
| n_max | Maximum number of patients that may be enrolled |
| sim_n | Number of simulated trials to create |
| pr_low | Lower probability limit for concluding treatment not promising |
| pr_high | Upper probablity limit for concluding treatment promising |
| mu_e | True rate of success with experimental treatment
in |
| verbose | When TRUE, additional information is returned as an attribute |
| quiet | Run with no notes, progress bars, etc. |
# simulate trial results sim_results <- ph2_single_bayes_seq_sim( # setting priors for standard treatment omega_s_mu = 0.2, omega_s_width = 0.20, omega_s_w_conf_level = 0.90, # setting priors for experimental treatment omega_e_c = 2, delta_0 = 0.15, # other trial parameters n_min = 10, n_max = 65, pr_low = 0.05, pr_high = 0.95, # true effect of experimental tx mu_e = 0.35, # number of simulations sim_n = 1000 ) # tabulate summary library(gtsummary) sim_results %>% dplyr::select(-sim_id) %>% tbl_summary( label = list(result ~ "Trial Result", n_enrolled ~ "No. Enrolled in Trial") ) %>% add_stat_label() %>% as_kable()#> #> #> |**Characteristic** |**Statistic** |**N = 1000** | #> |:---------------------|:-------------|:------------| #> |Trial Result | | | #> |futile |n (%) |158 (16%) | #> |inconclusive |n (%) |759 (76%) | #> |success |n (%) |83 (8.3%) | #> |No. Enrolled in Trial |median (IQR) |65 (65, 65) |


Welcome
! You've been successfully authenticated :)
Your state is:
Your profile image is:
Read in English
"Hi, my name is Sean" in French


1시간 59분의 신기록, 인간 한계의 무한한 가능성을 보여준 엘리우드 킵초게를 기념하는 컬렉션을 만나보세요.
Eliud Kipchoge
hover하면 기울어짐
upper
그림자 넣어보기
양쪽정렬 예제보기 According to figures published by the Ministry of Public Security this week, there were 10.03 million new babies registered in 2020, compared to 11.79 million the year before -- a decrease of 14.9%. The news comes as last year, China recorded the lowest birthrate since the People's Republic was founded in 1949.


Technologist/Foundry Engineer - Sunnyvale, CA 94085
Technologist/Foundry Engineer with a passion for product development to support SOC and Mixed Signal ASIC product development.
The position will support for new product development on exciting new projects. The will be involved in technology assessment, technology development, product design support and device development support as well as other interesting challenges as we strive to push the limits of our products.
The position requires someone with experience in the Fabless semiconductor model with some experience in custom process and custom library development. Candidate should have a good understanding of device physics, transistor modeling, fabrication processes for a wide range of technology nodes, device reliability, statistical analysis, yield improvement, and physical failure analysis techniques.
Required Experience and Skills
Experience in Foundry management or technology development for digital and mixed signal processes
Excellent understanding of fabrication technology from 0.18HV to the latest technologies
Excellent device physics knowledge
Experience in support design teams with PDKs, IP development, PPA analysis and tapeout
Experience in developing DFM requirements
Experience in establishing design for reliability requirements
Experience in implementation of test chips and test structures
Excellent probability and statistics back ground
Experience in process, device and product qualification
Skilled in data analysis
Experience in yield improvement
Experience in PFA techniques
Experience in foundry management
Understanding of product development
Good understanding of circuits and layout
Strong presentation and communication skills
Background in design of experiments
Beneficial Experience and Skills
Understanding of product and test engineering
Understanding of packaging
Technology/module development
Good background in risk probability analysis
Image Sensor background
Educational Requirement
BS/MS/PhD Engineering, or Sciences
Ability to meet Microsoft, customer and/or government security screening requirements are required for this role. These requirements include, but are not limited to the following specialized security screenings: Microsoft Cloud Background Check: This position will be required to pass the Microsoft Cloud Background Check upon hire/transfer and every two years thereafter.
Microsoft is an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to age, ancestry, color, family or medical care leave, gender identity or expression, genetic information, marital status, medical condition, national origin, physical or mental disability, political affiliation, protected veteran status, race, religion, sex (including pregnancy), sexual orientation, or any other characteristic protected by applicable laws, regulations and ordinances. We also consider qualified applicants regardless of criminal histories, consistent with legal requirements. If you need assistance and/or a reasonable accommodation due to a disability during the application or the recruiting process, please send a request via the Accommodation request form.
Benefits/perks listed below may vary depending on the nature of your employment with Microsoft and the country where you work.


WITNESS LIST
Mental Health, Select Committee
August 16, 2016 - 10:00 AM
Homeless, Substance Abuse, and Veteran Services in Texas
On:
Ackerson, Scott (Haven for Hope)
Evans, Lewis (Center for Healthcare Services Mental Health Authority for Bexar County)
Feehery, Matt (THA)
Gaines, Sonja (The Health and Human Services Commission)
Garnett, Susan (MHMR of Tarrant County)
Granberry, Amy (Self)
Hanna, Sean (Texas Veterans Commission)
Hansch, Greg (National Alliance on Mental Illness (NAMI) Texas)
Humphrey, Cynthia (Self; Assoc. ofmsubstance abuse programs)
Hupp, Dr. Suzanna (The Health and Human Services Commission)
Lacefield lewis, Lauren (Department of state health services)
Metzinger, Janie (Mental Health AmericaofGreater Dallas)
Saxton, Josette (Texans Care for Children)
Solomon, Tony (Mental health america of greater houston)
Switzer, Gyl (Mental health america of texas)
Trejo, Naomi (Texas Department of Housing and Community Affairs)
Wilson, Kenneth (Haven for Hope)
Registering, but not testifying:
On:
Brown, Mary Rose (Haven for Hope)
1